Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles

Abstract

The blood–brain barrier (BBB), built by brain endothelial cells (BECs), is impermeable to biologics. Liposomes and other nanoparticles are good candidates for the delivery of biologics across the BECs, as they can encapsulate numerous molecules of interest in an omnipotent manner. The liposomes need attachment of a targeting molecule, as BECs unfortunately are virtually incapable of uptake of non-targeted liposomes from the circulation. Experiments of independent research groups have qualified antibodies targeting the transferrin receptor as superior for targeted delivery of nanoparticles to BECs. Functionalization of nanoparticles via conjugation with anti-transferrin receptor antibodies leads to nanoparticle uptake by endothelial cells of both brain capillaries and post-capillary venules. Reducing the density of transferrin receptor-targeted antibodies conjugated to liposomes limits uptake in BECs. Opposing the transport of nanoparticles conjugated to high-affine anti-transferrin receptor antibodies, lowering the affinity of the targeting antibodies or implementing monovalent antibodies increase uptake by BECs and allows for further transport across the BBB. The novel demonstration of transport of targeted liposomes in post-capillary venules from blood to the brain is interesting and clearly warrants further mechanistic pursuit. The recent evidence for passing targeted nanoparticles through the BBB shows great promise for future drug delivery of biologics to the brain.

Aptamers for Addressed Boron Delivery in BNCT: Effect of Boron Cluster Attachment Site on Functional Activity

“…Moreover, Waz binding with the receptor is followed by its cell internalization [20]. Second, the molecules that specifically bind TfR represent potential brain delivery agents that cross the blood-brain barrier [25][26][27], which is especially important for the development of glioblastoma-targeting agents. We supposed that a Waz aptamer could possibly bring a double advantage, both for brain delivery and for targeted transport into glioblastoma cells.…”

Polymeric Metal Contrast Agents for T1-Weighted Magnetic Resonance Imaging of the Brain

“…The addition of polymers to CAs will allow for increased bioconjugation functionality without disrupting any beneficial properties of the metal. Brain-targeting ligands − ,, like apolipoprotein E, − apolipoprotein B, − transferrin, − and insulin − have all been used to bypass the BBB in polymer-based delivery systems. Leveraging these advances using polymer-based systems to encapsulate and deliver CAs to the brain is a logical next step.…”

Food‐borne polyphenols: A biocompatible anchor recuperating iron homeostasis

“…Although the main driving factors have not been identified, iron accumulation may be due to the upregulation of DMT1 and iron regulatory protein (IRP), and downregulation of iron transporters and iron oxidase ceruloplasmin (Ward et al., 2022). With the help of transferrin, iron crosses the blood–brain barrier into neurons, a relatively isolated compartment that is susceptible to abnormal iron accumulation (Thomsen et al., 2022). Iron is deposited in specific regions of the brain, like SN in Parkinson's disease (PD) and hippocampus in Alzheimer's disease (AD).…”